
Metly
Metly empowers pharma companies to accelerate product launches through intelligent opportunity detection and partner matching.
About
Metly provides pharma intelligence that runs continuously in the background, aggregating data and automating intelligence workflows. Its core product helps pharmaceutical teams discover opportunities, monitor competitors, and automatically update deliverables by searching regulatory filings, clinical databases, and partnership signals. Metly serves pharmaceutical companies by putting their intelligence function on autopilot so teams can focus on what matters.
Key facts
At-a-glance profile data
- Website
- metly.ai
- Headquarters
- New York, United States
- Founded
- 2021
- Employees
- 10
- Total funding
- $2M (Pre-Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 22 Jul 2025 | Pre-Seed | $520K | Encomenda |
| 1 May 2023 | Undisclosed round | $2M | - |
Tech stack
Detected on metly.ai, last scanned 7 Sept 2026. Run your own scan
- Frontend
- Bootstrap
- Hosting
- Azure
- Email provider
- Google Workspace
Frequently asked
How much funding has Metly raised?
Metly has raised a total of $2M in funding. The most recent round on record is Pre-Seed.
How many employees does Metly have?
Metly has approximately 10 people on record.
